Namias A, Bhalotra R, Donowitz M
J Clin Gastroenterol. 1981 Jun;3(2):193-8. doi: 10.1097/00004836-198106000-00017.
Sulfasalazine, a drug common in the treatment of inflammatory bowel disease, may cause liver damage. We present a patient with documented granulomatous hepatitis which resolved on liver biopsy 6 weeks after discontinuation of the drug.
柳氮磺胺吡啶是治疗炎症性肠病的常用药物,可能会导致肝损伤。我们报告一例有记录的肉芽肿性肝炎患者,在停用该药物6周后的肝脏活检显示病情有所缓解。